Get In Touch Why Researchers Choose Retatrutide Retatrutide is gaining attention for its multi-receptor activity in metabolic research, targeting GLP-1, GIP, and glucagon pathways with strong study potential
SGLT1 in pancreatic cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications
Customs documentation requirements Successful customs clearance requires proper documentation
Urinary albumin over creatinine ratio in 49-wk old male DIO C57BL6/J mice after 14 days of daily s.c